Companies
Anvisa Approves Five New Semaglutide Pens, Heating Up Brazil's R$5.6 Billion Weight-Loss Drug War
Brazil's health regulator cleared five additional semaglutide pens from Sandoz, Sun Pharma, Ranbaxy, and Brainfarma, sha...
Declan Byrne
👁 2
💬 0
